Steris PLC
General ticker "STE" information:
- Sector: Health Care
- Industry: Health Care Equipment & Supplies
- Capitalization: $21.2B
Steris PLC follows the US Stock Market performance with the rate: 20.1%.
Estimated limits based on current volatility of 1.2%: low 203.64$, high 208.65$
Factors to consider:
- Company included in S&P500 list
- Company pays dividends: last record date 2024-11-19, amount 0.57$ (Y1.10%)
- US accounted for 72.3% of revenue in the fiscal year ended 2023-03-31
- Price in estimated range
- Earnings for 18 months up through Q2 (+1 year) exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-03-31 to 2025-03-30
- 2023-03-31 to 2024-03-30 estimated range: [178.52$, 238.16$]
- 2024-03-30 to 2025-03-30 estimated range: [197.39$, 262.20$]
Financial Metrics affecting the STE estimates:
- Positive: Non-GAAP EPS, $ of 8.21 > 2.29
- Negative: Investing cash flow per share, $ of -3.84 <= -3.48
- Positive: -0.25 < Return on assets ratio (scaled to [-100,100]) of 0.97
- Positive: 1.03 < Operating profit margin, % of 5.41
- Negative: Industry operating cash flow per share per price (median), % of -6.88 <= 3.85
Short-term STE quotes
Long-term STE plot with estimates
Financial data
| YTD | 2021-03-31 | 2022-03-31 | 2023-03-31 |
|---|---|---|---|
| Operating Revenue | $3,107.52MM | $4,585.06MM | $4,957.84MM |
| Operating Expenses | $2,559.15MM | $4,159.45MM | $4,689.65MM |
| Operating Income | $548.37MM | $425.62MM | $268.19MM |
| Non-Operating Income | $-30.84MM | $-111.11MM | $-110.84MM |
| Interest Expense | $37.18MM | $89.59MM | $109.62MM |
| R&D Expense | $66.33MM | $87.94MM | $101.58MM |
| Income(Loss) | $517.53MM | $314.50MM | $157.35MM |
| Taxes | $120.66MM | $71.63MM | $51.53MM |
| Profit(Loss) | $396.87MM | $242.87MM | $105.81MM |
| Stockholders Equity | $3,880.99MM | $6,532.36MM | $6,077.20MM |
| Inventory | $315.07MM | $575.00MM | $695.49MM |
| Assets | $6,574.47MM | $11,423.59MM | $10,821.84MM |
| Operating Cash Flow | $689.64MM | $684.81MM | $756.95MM |
| Capital expenditure | $239.26MM | $287.56MM | $361.97MM |
| Investing Cash Flow | $-1,154.16MM | $-666.56MM | $-383.33MM |
| Financing Cash Flow | $345.62MM | $115.83MM | $-498.72MM |
| Earnings Per Share* | $4.66 | $2.50 | $1.07 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.